ONYX PHARMACEUTICALS INC | 63,89 Euro | -0,81 -1,25 % | |
| WKN: 900778 ISIN: US6833991093 Ticker-Symbol: OX1 | Frankfurt | 20.06.13 | 08:03 Uhr |
Branche BiotechnologieAktienmarkt NASDAQ Biotech |
|
|
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 17.06. | Onyx Pharmaceuticals Crosses Below its 10-day MA | 3 | SmarTrend | |
| 13.06. | Possible Bullish Inside Day Candle Pattern Detected for Onyx Pharmaceuticals | 1 | SmarTrend | |
| 12.06. | Onyx Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-12-2013 10:00 AM | 3 | Seeking Alpha | |
| 06.06. | Onyx Pharmaceuticals to Present at Upcoming Investor Conferences / Webcasts Available on Corporate Website | 27 | Marketwired | |
| SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/06/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will present at two upcoming investor conferences in June and July.
Goldman... Mehr lesen zu: Onyx Pharmaceuticals to Present at Upcoming Investor Conferences / Webcasts Available on Corporate Website | ||||
| 06.06. | Onyx Pharmaceuticals - Doppeltop birgt Gefahr | 6 | GodmodeTrader.de | |
| 03.06. | SmarTrend Watching for Potential Rebound in Shares of Onyx Pharmaceuticals After 2.40% Loss | 5 | SmarTrend | |
| 03.06. | Onyx Pharmaceuticals Bearish Moving Average Crossover Alert | 2 | SmarTrend | |
| 03.06. | Onyx Pharmaceuticals and the UCSF Helen Diller Family Comprehensive Cancer Center Announce Oncology Innovation Alliance / Strategic Alliance Focused on Advancing Drug Discovery and Development | 37 | Marketwired | |
| SOUTH SAN FRANCISCO, CA and SAN FRANCISCO, CA -- (Marketwired) -- 06/03/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) and the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive... Mehr lesen zu: Onyx Pharmaceuticals and the UCSF Helen Diller Family Comprehensive Cancer Center Announce Oncology Innovation Alliance / Strategic Alliance Focused on Advancing Drug Discovery and Development | ||||
| 02.06. | Bayer HealthCare, Onyx Pharma Reveal Phase 3 DECISION Trial Results For Nexavar | 170 | AFX News | |
| WASHINGTON (dpa-AFX) - Bayer HealthCare Pharmaceuticals and Onyx
Pharmaceuticals, Inc. (ONXX) announced positive results from the Phase 3
DECISION trial investigating the use of Nexavar... Mehr lesen zu: Bayer HealthCare, Onyx Pharma Reveal Phase 3 DECISION Trial Results For Nexavar | ||||
| 31.05. | Onyx Pharma to Hold Call to Discuss Phase 3 DECISION Data at 2013 ASCO | 7 | Benzinga.com | |
| 31.05. | Onyx Pharmaceuticals Announces Conference Call to Discuss Phase 3 DECISION Data at 2013 ASCO Annual Meeting / Conference Call and Webcast Scheduled for Monday, June 3, 2013 at 10:15 a.m. Central Time | 49 | Marketwired | |
| SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/31/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will hold a conference call to discuss data presented at an ASCO plenary session... Mehr lesen zu: Onyx Pharmaceuticals Announces Conference Call to Discuss Phase 3 DECISION Data at 2013 ASCO Annual Meeting / Conference Call and Webcast Scheduled for Monday, June 3, 2013 at 10:15 a.m. Central Time | ||||
| 28.05. | Onyx Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 1.13% | 6 | SmarTrend | |
| 24.05. | Possible Bearish Inside Day Candle Pattern Detected for Onyx Pharmaceuticals | 4 | SmarTrend | |
| 23.05. | Onyx Pharmaceuticals Crosses Above its 10-day MA | 1 | SmarTrend | |
| 22.05. | Onyx Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 10:30 AM | 7 | Seeking Alpha | |
| 21.05. | Onyx Pharmaceuticals Announces Data Presentations at the 18th Congress of the European Hematology Association | 34 | Marketwired | |
| SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/21/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentation of data highlighting Kyprolis® (carfilzomib) for Injection... Mehr lesen zu: Onyx Pharmaceuticals Announces Data Presentations at the 18th Congress of the European Hematology Association | ||||
| 20.05. | Onyx Pharmaceuticals Earnings Review: 13 Days after Announcement Shares Up 5.6% | 1 | SmarTrend | |
| 16.05. | Onyx Pharmaceuticals Announces Data Presentations at 49th American Society of Clinical Oncology Annual Meeting | 50 | Marketwired | |
| SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/15/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentations of data highlighting Nexavar® (sorafenib) tablets, Kyprolis®... Mehr lesen zu: Onyx Pharmaceuticals Announces Data Presentations at 49th American Society of Clinical Oncology Annual Meeting | ||||
| 08.05. | Onyx Pharmaceuticals to Present at Upcoming Investor Conferences / Webcasts Available on Corporate Website | 28 | Marketwired | |
| SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/08/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will present at two upcoming investor conferences in May.
Bank of America... Mehr lesen zu: Onyx Pharmaceuticals to Present at Upcoming Investor Conferences / Webcasts Available on Corporate Website | ||||
| 08.05. | Barclays erhöht das Kursziel für Onyx Pharma von $93 auf $98 | 98 | BörseGo | |
| Barclays erhöht das Kursziel für Onyx Pharma von $93 auf $98
(© BörseGo AG 2013 - Autor: Tobias Krieg, Redakteur) Mehr lesen zu: Barclays erhöht das Kursziel für Onyx Pharma von $93 auf $98 | ||||
Seite: 1 2 3 4 5 ... Weiter >>
115 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| QIAGEN | 14,585 | -1,35 % | Qiagen sichert sich weitere Rechte an Krebsbiomarkern |
| MEDIGENE | 0,989 | +0,71 % | Medigene: Kursziel steigt vor Zusammenlegung |
| AMGEN | 74,52 | -1,95 % | Amgen Award For Science Teaching Excellence Honors Outstanding Teachers |
| MORPHOSYS | 37,90 | -1,52 % | MorphoSys AG: Veröffentlichung gem. § 26 Abs.1 WpHG mit dem Ziel der europaweiten Verbreitung |
| EVOTEC | 2,695 | -2,57 % | Evotec-Aktie: Wohin geht die nächste Reise? |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von